Trial intelligence / Profile preview

Euphorbia Prostrata Extract in Hemorrhoids

NCT01041911Phase 2Completed

Sponsor
Panacea Biotec
Start
Mar 2010
Primary completion
Oct 2010
Modality
PE (Plant Extract)
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of euphorbia prostrata extract in Hemorrhoids (4 arms), sponsored by Panacea Biotec. Primary endpoint: Proportion of subjects achieving cessation of per rectal bleeding at 14 days. Started Mar 2010; status: completed.

02

Drugs

euphorbia prostrata extract
03

Conditions

Hemorrhoids

Beyond the preview

Go deeper on NCT01041911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01041911.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call